Trisalus Life Sciences Inc (TLSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,223 | 2,837 | 4,767 | 1,872 | 7 |
| Other Working Capital | -136 | 244 | 1,303 | 842 | 400 |
| Other Operating Activity | -6,209 | -3,507 | -7,808 | -3,771 | -1,099 |
| Operating Cash Flow | $-1,123 | $-426 | $-1,738 | $-1,057 | $-692 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 91 | 11 | 60 | 0 | 0 |
| Investing Cash Flow | $91 | $11 | $60 | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 900 | 265 | 544 | 0 | 0 |
| Financing Cash Flow | $900 | $265 | $544 | $0 | $0 |
| Beginning Cash Position | 201 | 201 | 1,335 | 1,335 | 1,335 |
| End Cash Position | 69 | 51 | 201 | 278 | 643 |
| Net Cash Flow | $-132 | $-150 | $-1,134 | $-1,057 | $-692 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,123 | -426 | -1,738 | -1,057 | -692 |
| Free Cash Flow | -1,123 | -426 | -1,738 | -1,057 | -692 |